# OnCo record dalteparin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/dalteparin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "dalteparin" ;
  schema:name "Dalteparin"@en ;
  schema:alternateName "dalteparin sodium"@en, "Fragmin" ;
  schema:description "Dalteparin is a daily blood-thinning injection. Its US label is one of the few written for people with cancer: it treats a clot and keeps giving protection for six months so that another clot is less likely."@en ;
  schema:url <https://onco.cc/drugs/dalteparin/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Dalteparin> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=23527b8b-9b28-4e6d-9751-33b143975ac7>, <https://doi.org/10.1016/S1470-2045(22)00160-7> ;
  onco:status "approved" ;
  onco:tag "supportive", "generic", "supportive-care-gaps-2026-11" ;
  onco:modality "Low-molecular-weight heparin (injection)" ;
  onco:approval "US 1994: Extended treatment of symptomatic VTE to reduce recurrence in adults with cancer (six months); DVT prophylaxis; unstable angina; VTE in children" ;
  onco:related <https://onco.cc/drugs/enoxaparin/>, <https://onco.cc/drugs/tinzaparin/>, <https://onco.cc/drugs/apixaban/> ;
  onco:technologies <https://onco.cc/technologies/cancer-associated-thrombosis/> ;
  onco:terms <https://onco.cc/terms/vte/> .